A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins

Clinical trial NCT00211029 · COMPLETED

Trial details

NCT number: NCT00211029
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Study type: OBSERVATIONAL

Red-Cell Aplasia, Pure

Start date: 2003-01-01
Primary completion: 2005-07-01
Enrollment: 4670

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.